erdafitinib
medsir,janssen
['solid tumor', 'erdafitinib', 'medsir']
informative talk on erdafitinib for advanced solid tumors w/ fgfralt
- orr 29.2%, dcr 72.5%, median dor 7.1m
-66.3% of pts had a reduction in tumor burden
-durable response across 14 tumor types
- teaes were consistent with known safety profile
#asco22 
Bring your idea to life?? 
Creating successful IITs & optimizing drug development ?? 
Medica Scientia Innovation Research
 ????&????
https://t.co/yp3O5Lylqc